Daniel O Day
Tracked across 1 events · 6 articles · First seen Apr 07, 2026 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Daniel O Day, Chairman and CEO of Gilead Sciences, commented on the acquisition, highlighting its significance for Gilead Sciences' oncology progress and the strong conviction in Tubulis' programs.
Apr 07, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Daniel O Day live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard